Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorte Renneberg

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chembiochem : a European Journal of Chemical Biology|August 10, 2004
Exploring Hoogsteen and reversed-Hoogsteen duplex and triplex formation with tricyclo-DNA purine sequencesDorte Renneberg, Christian J Leumann
Journal of the American Chemical Society|May 23, 2002
Watson-Crick base-pairing properties of tricyclo-DNADorte Renneberg, Christian J Leumann
Journal of the American Chemical Society|May 8, 2003
Imidazopyridine/Pyrrole and hydroxybenzimidazole/pyrrole pairs for DNA minor groove recognitionDorte Renneberg, Peter B Dervan
Nucleic Acids Research|January 17, 2004
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNADamian Ittig, Songkai Liu, Dorte Renneberg, et al.
Nucleic Acids Research|June 28, 2002
Antisense properties of tricyclo-DNADorte Renneberg, Emilie Bouliong, Ulrich Reber, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2015
Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockersDorte Renneberg, Francis Hubler, Markus Rey, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2013
Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffoldAnja Valdenaire, Julien Pothier, Dorte Renneberg, et al.
Journal of Medicinal Chemistry|March 14, 2024
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing <i>In Vivo</i> ActivityFrancis Hubler, Dorte Renneberg, Hervé Siendt, et al.
Journal of Medicinal Chemistry|November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than ClopidogrelEva Caroff, Francis Hubler, Emmanuel Meyer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chembiochem : a European Journal of Chemical Biology|August 10, 2004
Exploring Hoogsteen and reversed-Hoogsteen duplex and triplex formation with tricyclo-DNA purine sequencesDorte Renneberg, Christian J Leumann
Journal of the American Chemical Society|May 23, 2002
Watson-Crick base-pairing properties of tricyclo-DNADorte Renneberg, Christian J Leumann
Journal of the American Chemical Society|May 8, 2003
Imidazopyridine/Pyrrole and hydroxybenzimidazole/pyrrole pairs for DNA minor groove recognitionDorte Renneberg, Peter B Dervan
Nucleic Acids Research|January 17, 2004
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNADamian Ittig, Songkai Liu, Dorte Renneberg, et al.
Nucleic Acids Research|June 28, 2002
Antisense properties of tricyclo-DNADorte Renneberg, Emilie Bouliong, Ulrich Reber, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2015
Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockersDorte Renneberg, Francis Hubler, Markus Rey, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2013
Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffoldAnja Valdenaire, Julien Pothier, Dorte Renneberg, et al.
Journal of Medicinal Chemistry|March 14, 2024
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing <i>In Vivo</i> ActivityFrancis Hubler, Dorte Renneberg, Hervé Siendt, et al.
Journal of Medicinal Chemistry|November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than ClopidogrelEva Caroff, Francis Hubler, Emmanuel Meyer, et al.
Pageof 1